Russell Investments Group
SRRA

Russell Investments Group’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Russell Investments Group’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-504
Closed -$34K – 2996
2019
Q1 		$34K Buy
504
+43
+9% +$2.76K ﹤0.01% 2844
2018
Q4 		$24K Hold
461
– – ﹤0.01% 2854
2018
Q3 		$31K Buy
461
+100
+28% +$9.07K ﹤0.01% 2886
2018
Q2 		$43K Buy
+361
New +$36.2K ﹤0.01% 2824

Other funds holding SRRA

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Russell Investments Group's SRRA Position: Q2 2019 in Review

Russell Investments Group sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q2 2019, closing a stake of 504 shares — an estimated $34K sold.

Russell Investments Group first reported a position in SRRA in Q2 2018 and held it in 4 quarters. The position peaked at $43K in Q2 2018. 49 funds tracked by Wall St. Rank hold SRRA as of Q2 2019.

  • Russell Investments Group reported no remaining Sierra Oncology, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Russell Investments Group sold 504 Sierra Oncology, Inc. Common Stock shares in Q2 2019, an estimated $34K.
  • Russell Investments Group first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2018 and held it in 4 quarters.
  • Russell Investments Group's Sierra Oncology, Inc. Common Stock position peaked at $43K in Q2 2018.
  • 49 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q2 2019.

Based on Russell Investments Group's 13F filing for Q2 2019, filed 9 Aug 2019.